Why OptimizeRx (OPRX) Stock Fell 16.43% in 10 Minutes After Earnings on Nov 11, 2026
Adjusted EPS of $0.20 came in above the $0.17 estimate; revenue of $21.61 million came in above the $21.19 million estimate.
- OPRX fell 16.43% in the 10 minutes after the 16:01:55 ET headline, from $8.95 to $7.48.
- 11,471 shares changed hands in those 10 minutes.
- The headline crossed in after-hours trading, 1 minute after the 4:00 ET close.
16:01:55 ET
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| OPRX | 8.95 | 8.95 | 7.84 | 7.48 | -12.40% | -16.43% |
OptimizeRx (OPRX) shares fell 16.43% in the 10 minutes after its results reached the MoveSurge news feed at 16:01:55 ET on Wednesday, November 11, 2026. Adjusted EPS of $0.20 came in above the $0.17 estimate; revenue of $21.61 million came in above the $21.19 million estimate.
OPRX in the first 10 minutes
The line that crossed at 16:01:55 ET: “OPRX: FY2026 Sales guidance lowered to USD 87mln-USD 93mln from USD 95mln-USD 100mln vs est. USD 96.23mln”
From a reference price of $8.95 just before the headline, the stock was down 12.40% after one minute and down 16.43%, at $7.48, after 10 minutes. The move kept building after the first minute. 11,471 shares changed hands in those 10 minutes. The headline crossed in after-hours trading, 1 minute after the 4:00 ET close.
OptimizeRx results against estimates
| Measure | Reported | Estimate | Result |
|---|---|---|---|
| Adjusted EPS | $0.20 | $0.17 | Beat |
| Revenue | $21.61 million | $21.19 million | Beat |
OptimizeRx FY26 guidance
| Measure | New range | Prior range | Estimate | Change |
|---|---|---|---|---|
| Revenue | $87 million to $93 million | $95 million to $100 million | $96.23 million | Lowered |
How OPRX traded after earlier earnings releases
| Report | EPS vs estimate | Revenue vs estimate | First move |
|---|---|---|---|
| Aug 12, 2026 | $0.16 vs $0.12 | $20.5 million vs $20.2 million | not measured |
| May 12, 2026 | $0.14 vs $0.00 | $19.84 million vs $18.35 million | not measured |
OptimizeRx at a glance
| Sector | Consumer Discretionary |
| Industry | Business Services |
| Market value | $176 million (as of Nov 12, 2026) |
Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.
How did OptimizeRx stock react to its earnings on November 11, 2026?
The stock fell 16.43% in the 10 minutes after its results crossed at 16:01:55 ET. Adjusted EPS of $0.20 came in above the $0.17 estimate; revenue of $21.61 million came in above the $21.19 million estimate.
How far did OPRX move after the headline?
From $8.95 just before the headline to $7.48 10 minutes later, a -16.43% move.
What did OptimizeRx guide for revenue?
Revenue guidance of $87 million to $93 million, replacing $95 million to $100 million; the estimate was $96.23 million (lowered).
Sources
-
OPRX headline and measured reaction, Nov 11, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Never miss the next market-moving story
Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.
Go live — 7 days for $29 Watch live headlines -- free